Posted on Leave a comment

8.Finance raised $215k in the Seed round

8.Finance is an educational and marketing platform with a simple “Snake for Crypto” game that aims to onboard the next billion crypto users and educate them to make their path smooth and safe. It is the second investor of the project. The previous investor bought their tokens at the Pre-Seed round for $300k. So, they have already […]

Posted on Leave a comment

TC BioPharm Ltd ($TCBP) leads fight against Acute myeloid leukemia with its cell therapy product OmnImmune

Scientific advances are creating new ways, previously only imaginable, to treat and prevent diseases. Stocks were mixed Monday in a volatile session to start a short trading week due to the Thanksgiving holiday. Fears that China may again ramp up Covid restrictions after reporting deaths from the virus weighed on markets, sending energy stocks and […]

Posted on Leave a comment

Ohana Legacy Properties Recommends Ways to Avoid Probate

Let Ohana Legacy Properties Help You Go Through the Probate Process in Houston TX How Ohana Legacy Properties Can Help Homeowners Prevent Their Homes from Going into Probate Following a person’s death, their will and assets will have to undergo probate before an executor can distribute the assets. Unfortunately for the surviving family members, this […]

Posted on Leave a comment

KULR Inks Battery Safety Deal With Largest U.S Auto Manufacturer, Shares Push To Multi-Month Highs ($KULR)

KULR Technology (NYSE: KULR) stock is fighting off broader market bearish sentiment, holding near its multi-month high despite a weakening sector backdrop. On Thursday, KULR was trading at $1.94, shy of the highs set in October but still up by about 51% since the start of last month. While the rally started in October, it’s […]

Posted on Leave a comment

KULR Stock Ramps Higher After Announcing Battery Safety Deal With Largest U.S Auto Manufacturer ($KULR)

KULR Technology (NYSE: KULR) stock is in full-scale rally mode. Shares first ripped about 17% higher after providing solid Q3 performance and bullish guidance for Q4 and 2023. The rally gained momentum after another update indicated add-on orders from at least two global business leaders. One came from Lockheed Martin (NYSE: LMT), and the other […]

Posted on Leave a comment

KULR Stock Higher After Earnings; Guidance Calls For Accelerating Growth In Q4 And 2023 ($KULR)

KULR Technology (NYSE: KULR) stock ripped about 17% higher after investors digested numbers and guidance from its Q3 report. The company posted a 133% increase in comparative quarterly revenues, held $16.2 million in cash at the end of Q3, and noted in its commentary that the quarter was an inflection point, reaching record-setting revenues as […]

Posted on Leave a comment

OneMeta AI’s Verbum Is More Than A Best-In-Class Translation App, It’s Expected To Be An Enormous Near-Term Value Driver ($ONEI)

Having transformative technology and assets can quickly turn smallcaps into large caps, and OneMeta AI (Ticker: ONEI) has positioned itself to prove that point. That’s no overzealous presumption. It’s a sentiment based on ONEI having, among other things, a proven and working language translation app separating itself from everything in the industry. And by no […]

Posted on Leave a comment

Solar Integrated Roofing Corp. Stock Trends Higher; Expectations Of More Record-Setting Quarters Fuel Interest (OTC: SIRC)

Solar Integrated Roofing Corp. (OTC: SIRC) is an intriguing company and stock. And part of the reason is that from a revenue and income perspective, many investors would say its stock price might be more fairly represented at midcap levels. The disconnect there is that it’s not.  Strangely, despite expectations to post over $200 million […]

Posted on Leave a comment

Acurx Pharmaceuticals’ Stock In Play As New Clinical Data Supports Ibezapolstat As A Potential Front-Line Treatment For C. Difficile Infections ($ACXP)

Acurx Pharmaceuticals (NasdaqCM: ACXP) stock is again in play. And for good reasons. In October, ACXP released additional positive clinical data evaluating ibezapolstat, its orally administered antibiotic being developed as a Gram-Positive Selective Spectrum (GPSS™) antibacterial. Following precedent, the data was impressive. Two presentations, one a scientific oral presentation and the other a poster, detailed […]